Trials / Sponsors / Indapta Therapeutics, INC.
Indapta Therapeutics, INC.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis Multiple Sclerosis, Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS) | Phase 1 | 2026-06-30 |
| Recruiting | IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Can NHL, Multiple Myeloma, Blood Cancer | Phase 1 / Phase 2 | 2023-10-25 |